Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1754studies shown

Showing 1,273-1,284 of 1,754

Drug study icon

RecruitingNCT04123314

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 85 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Depression

Drug study icon

RecruitingNCT06899594

Psilocybin for Methamphetamine Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 25 Years to 65 Years

Countries: United States
Sponsor: Kevin Murnane
Condition: Addiction

Drug study icon

RecruitingNCT06355414

Psilocybin in Chronic Low Back Pain and Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 21 Years to 80 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Depression

Drug study icon

RecruitingNCT07226232

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Depression

Drug study icon

RecruitingNCT06810310

Psilocybin on Brain Mechanisms of Motivation in OUD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Addiction

Drug study icon

RecruitingNCT06405607

Psilocybin or Ketamine for Addiction: An Active Comparator study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: University of Iowa
Condition: Addiction

Drug study icon

RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 22 Years to 65 Years

Countries: United States
Sponsor: University of Texas at Austin
Condition: Depression

Drug study icon

RecruitingNCT06455293

Psilocybin Therapy for Depression in Parkinson's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 40 Years to 80 Years

Countries: United States
Sponsor: Joshua Woolley, MD, PhD
Condition: Depression

Drug study icon

RecruitingNCT07251491

Psilocybin to Treat Depression in Spinal Cord Injury

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugOver 22 Years

Countries: United States
Sponsor: James J. Peters Veterans Affairs Medical Center
Condition: Depression

Drug study icon

RecruitingNCT07347405

Psilocybin Whole Mushroom for OCD.

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugOver 18 Years

Countries: United States
Sponsor: Francisco A Moreno
Condition: OCD

Drug study icon

RecruitingNCT06592833

Psilocybin With Pimavanserin Compared to Psilocybin Alone for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 21 Years to 80 Years

Countries: United States
Sponsor: Icahn School of Medicine at Mount Sinai
Condition: Depression

Drug study icon

RecruitingNCT06200155

Psilocybin-Assisted Psychotherapy in people with Advanced Cancer on Maintenance Therapy

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Anxiety, DepressionDrugOver 25 Years

Countries: United States
Sponsor: M.D. Anderson Cancer Center
Condition: Anxiety, Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.